{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:49:53Z","timestamp":1792014593431,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijrobp.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:15:20Z","timestamp":1779466520000},"page":"1293-1301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proton Beam Therapy for Large Localized Hepatocellular Carcinomas in Western Patients"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3890-6276","authenticated-orcid":false,"given":"Kanokphorn","family":"Thonglert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie K.","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Nyflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Grassberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Menghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4522-8300","authenticated-orcid":false,"given":"Smith","family":"Apisarnthanarax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.05.013_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0030-1247133","article-title":"Current strategy for staging and treatment: The BCLC update and future prospects","volume":"30","author":"Forner","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0002","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0003","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0004","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: Patterns, treatments, and prognosis","volume":"261","author":"Tabrizian","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0005","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1200\/JCO.2002.20.6.1527","article-title":"Simplified staging for hepatocellular carcinoma","volume":"20","author":"Vauthey","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0006","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1148\/radiol.12121698","article-title":"New OPTN\/UNOS policy for liver transplant allocation: Standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma","volume":"266","author":"Wald","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0007","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","article-title":"Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-expanded criteria based on preoperative imaging","volume":"7","author":"Yao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0008","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2147\/CMAR.S147097","article-title":"Extrahepatic metastasis risk of hepatocellular carcinoma based on \u03b1-fetoprotein and tumor staging parameters at cross-sectional imaging","volume":"9","author":"Yokoo","year":"2017","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0009","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiology.214.3.r00mr02761","article-title":"Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions","volume":"214","author":"Livraghi","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0010","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1148\/radiol.2343040153","article-title":"Radiofrequency ablation of hepatocellular carcinoma: Treatment success as defined by histologic examination of the explanted liver","volume":"234","author":"Lu","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0011","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.sla.0000143301.56154.95","article-title":"Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: A prospective study","volume":"240","author":"Mazzaferro","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0012","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.hpb.2017.03.009","article-title":"Systematic review and meta-analysis of hepatic resection versus transarterial chemoembolization for solitary large hepatocellular carcinoma","volume":"19","author":"Stevens","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0013","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.1840160212","article-title":"Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma","volume":"16","author":"Vilana","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.04.024","article-title":"Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion","volume":"134","author":"Mathew","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818790217","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: Current trends and controversies","volume":"17","author":"Schaub","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0016","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clon.2020.01.028","article-title":"Stereotactic body radiotherapy for large unresectable hepatocellular carcinomas \u2013 A single institution phase II study","volume":"32","author":"Beaton","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20181053","article-title":"Stereotactic body radio therapy for inoperable large hepatocellular cancers: Results from a clinical audit","volume":"92","author":"Chopra","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0018","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1748-717X-9-120","article-title":"The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities","volume":"9","author":"Que","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0019","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1016\/j.prro.2025.05.016","article-title":"Long-term outcome of stereotactically designed hypofractionated image guided radiation therapy in large, unresectable hepatocellular carcinoma","volume":"15","author":"Wong","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/hepr.12874","article-title":"Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm","volume":"47","author":"Kimura","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/cancers10030071","article-title":"Proton beam therapy without fiducial markers using four-dimensional CT planning for large hepatocellular carcinomas","volume":"10","author":"Shibata","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0022","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijrobp.2009.02.030","article-title":"Proton beam therapy for large hepatocellular carcinoma","volume":"76","author":"Sugahara","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0023","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2018.10.041","article-title":"Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma","volume":"133","author":"Chadha","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.959552","article-title":"Proton therapy in the treatment of hepatocellular carcinoma","volume":"12","author":"Dionisi","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib43","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver Imaging Reporting and Data System (LI-RADS) version 2018: Imaging of hepatocellular carcinoma in at-risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0025","article-title":"Simultaneous integrated boost and protection proton beam therapy approach for hepatocellular carcinoma","volume":"54","author":"Thonglert","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0026","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ijrobp.2021.10.006","article-title":"LI-RADS Treatment Response Algorithm: Performance and diagnostic accuracy with radiologic-pathologic explant correlation in patients with SBRT-treated hepatocellular carcinoma","volume":"112","author":"Mendiratta-Lala","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0027","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232408","article-title":"CT\/MRI LI-RADS 2024 update: Treatment response assessment","volume":"313","author":"Aslam","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0028","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, 2017, https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf. Accessed February 3, 2025."},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.prro.2017.10.013","article-title":"Toward consensus reporting of radiation-induced liver toxicity in the treatment of primary liver malignancies: Defining clinically relevant endpoints","volume":"8","author":"Chapman","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ijrobp.2023.09.049","article-title":"Clinical and dosimetric results of proton or photon radiation therapy for large (>5 cm) hepatocellular carcinoma: A retrospective analysis","volume":"118","author":"Hsieh","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0031","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2016.02.027","article-title":"Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: Results of an interim analysis","volume":"95","author":"Bush","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0032","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/cncr.34965","article-title":"Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial","volume":"129","author":"Bush","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0033","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0034","unstructured":"Radiation therapy with protons or photons in treating patients with liver cancer, ClinicalTrials.gov identifier: NCT03186898. https:\/\/clinicaltrials.gov\/study\/NCT03186898, Accessed February 2, 2025."},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13014-023-02318-0","article-title":"Radiation dose is associated with improved local control for large, but not small, hepatocellular carcinomas","volume":"18","author":"Amit","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0036","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2019.02.032","article-title":"Predictors of radiation-induced liver disease in eastern and western patients with hepatocellular carcinoma undergoing proton beam therapy","volume":"105","author":"Hsieh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0037","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaoncol.2024.5403","article-title":"Stereotactic body radiotherapy vs sorafenib alone in hepatocellular carcinoma: The NRG Oncology\/RTOG 1112 phase 3 randomized clinical trial","volume":"11","author":"Dawson","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0038","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): A randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0039","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jvir.2025.03.006","article-title":"Outcomes of transarterial hepatic embolization versus yttrium-90 radioembolization for treatment of patients with hepatocellular carcinoma >7 cm","volume":"36","author":"Son","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0040","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3390\/diagnostics15182297","article-title":"Assessment of preprocedural factors associated with 5-year complete response after transarterial radioembolization in patients with hepatocellular carcinoma","volume":"15","author":"Park","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0041","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jamaoncol.2024.4085","article-title":"Complete response to locoregional therapy plus immunotherapy for hepatocellular carcinoma","volume":"10","author":"Chiang","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.013_bib0042","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): A randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626007273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626007273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:12:42Z","timestamp":1792012362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626007273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0360301626007273"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.05.013","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Beam Therapy for Large Localized Hepatocellular Carcinomas in Western Patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}